SPECTRUM PHARMACEUTICALS INC·4

Feb 24, 5:08 PM ET

LEBEL FRANCOIS 4

4 · SPECTRUM PHARMACEUTICALS INC · Filed Feb 24, 2021

Insider Transaction Report

Form 4
Period: 2021-02-18
LEBEL FRANCOIS
Chief Medical Officer
Transactions
  • Award

    Common Stock, $0.001 par value

    2021-02-18+110,309418,526 total
  • Award

    Stock Option (Right to Buy)

    2021-02-18+133,708133,708 total
    Exercise: $3.56Exp: 2031-02-18Common Stock (133,708 underlying)
  • Award

    Stock Appreciation Right

    2021-02-18+314,213314,213 total
    Exercise: $3.56Exp: 2031-02-18Common Stock (314,213 underlying)
Holdings
  • Common Stock, $0.001 par value

    (indirect: By 401(k))
    7,226
Footnotes (3)
  • [F1]One third of the aggregate amount of restricted shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
  • [F2]One third of the aggregate amount of option shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
  • [F3]One third of the aggregate amount of stock appreciation rights shall vest on each of February 18, 2022, 2023 and 2024, respectively.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION